ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2336

Splinting for Trigger Finger. Short Term Effects

V. De Cillis1, A. Perez Davila2, A. Bohr3 and E. Scheines4, 1Occupational Therapy, Hospital de Rehabilitacion Manuel Rocca, Buenos Aires, Argentina, 2Rheumatology, Hospital de Rehabilitación Manuel Rocca, Ciudad Autonoma de Buenos Aires, Argentina, 3Rheumatology, Hospital Manuel Rocca, Ciudad Autonoma de Buenos Aires, Argentina, 4Rheumatology, Hospital Manuel Rocca, Buenos Aires, Argentina

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Hand disorders, orthotics and rehabilitation

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Orthopedics, Low Back Pain and Rehabilitation - ARHP Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Inflammatory processes of flexor tendons of fingers can produce pain and less (impaired) functionality. Trigger finger (stenosing tenosynovitis) is frequently seen in clinical practice. It is characterized by pain, snapping or locking when flexing the finger. The European consensus guideline for managing trigger finger suggests different interventions according to severity and duration of symptoms (orthoses/splints, corticosteroid injections, and surgical treatment.) Splinting is often indicated in order to prevent tendon friction. Among the different types of splinting, the experts recommend those that provide 0° metacarpophalangeal (MCF) blocking to avoid movement and load of the tendon through the A1 pulley. The aim of this study is to determine the short term effectiveness of splinting for trigger finger according to severity and duration of symptoms.

Methods: We included patients with Trigger finger diagnosis, type 1 to 3 according to Quinnell grading classification (mild, moderate, severe symptoms) who was under stable medication. Patients that received physiotherapy treatment and corticosteroid injections within 2 months before entry were excluded. Subjects were evaluated at admission and 30 days after using the splint with pain VAS, hand strength (jamar dynamometer), ability and dexterity (Picking up test) and global impact of hand disorders in daily activities (DASH disabilities of the arm, shoulder and hand). They were equipped with trigger finger splint providing 0° blocking of MCF to prevent sliding and tendon load through the A1 pulley. Patients used the splint for four weeks to perform daily activities.

Results: 15 patients were included (13 women and 2 men), 90% with trigger finger type 2/3 of Quinnell classification and 1 to 5 months of symptoms duration. 100% improved performance of daily activities according to DASH questionnaire. In 80% a decrease in frequency of locking, stiffness of the hand and fingers flexion were observed. We could not find changes in pain and strength parameters.

Conclusion: All the patients included improved the ability to perform daily activities after a month of splinting; and in most of the patients a decrease in the frequency of locking during finger flexion was noted. Even when these results are encouraging, it would be useful to increase the sample size and compare the splinting with other therapeutic modalities for the conservative treatment of trigger finger.


Disclosure: V. De Cillis, None; A. Perez Davila, None; A. Bohr, None; E. Scheines, None.

To cite this abstract in AMA style:

De Cillis V, Perez Davila A, Bohr A, Scheines E. Splinting for Trigger Finger. Short Term Effects [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/splinting-for-trigger-finger-short-term-effects/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/splinting-for-trigger-finger-short-term-effects/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology